Oncology Intelligence

Powering Precision Oncology from Research to Diagnostics

Bg bg-min
Rectangle 54-2

The Power of AI: Revolutionizing and Democratizing Cancer Diagnosis - Fortune Health 2022

Our Mission

Empowering physicians with immediate oncology intelligence to facilitate optimal treatment for more cancer patients

Learn More

Experts say about us

“Imagene’s technology can unlock precise and crucial information in real-time, changing the way cancer is diagnosed and treated.”

Group 146-2

Dr. David Agus

Founding Director and CEO

Lawrence J. Ellison Institute for Transformative Medicine

"Oncologists already use clinical features to manage decision-making and influence when additional narrow but rapid tests might be helpful for optimizing time or tissue utilization. I would definitely use a science-forward, reliable, and ultra-rapid AI test to enhance this process in supporting an informed clinical decision."

Mask-Group-Ross

Prof. Ross Camidge

Director of Thoracic Oncology

University of Colorado

"This is a breakthrough technology that has been tested in deep collaboration with the physicians of our pathology lab" 

Mask Group

Prof. Iris Barshak

Head of Pathology

Sheba Medical Center

"Saving lives is technology's single most important use. We are proud that Oracle's highly performant and secure cloud infrastructure will help Imagene improve access to care, drive informed decisions, lower costs, and ultimately save lives."

Mask-Group-safra

Safra Catz

CEO

Oracle

“Unfortunately, we are so used to waiting a long time for molecular cancer testing while patients deteriorate, that such a breakthrough technology, enabling treatment initiation within a day is exceptional.”

Group-146-8

Prof. Ido Wolf

Director of Oncology

Tel Aviv Sourasky Medical Center

“The pathology dept. at Ichilov participates in research and development of many new and advanced technologies, but it is rarely that we see a direct and meaningful impact on patients’ lives. We are excited about the opportunity to partner with Imagene to improve quality of care and impact patients’ lives.”

Group 136

Prof. Dov Hershkovitz

Director of Pathology

Tel Aviv Sourasky Medical Center

"Traditional molecular biomarker testing is expensive and can take weeks for patients to receive their results. Imagene's AI-based biomarker detection shows great promise for significantly reducing the waiting time for patients to begin targeted therapies.”

Mask-Group-Haog

David R. Braxton M.D.

Chief of Molecular Pathology

Hoag Family Cancer Institute

A New Standard for Biomarker ProfilingFrom Weeks to Minutes

Schedule a demo
bg-home-demo

AI-based Biomarker Profiling

icon-real-time-diagnosis

Rapid biomarker profiling - within minutes

icon-image-only3

Image-based analysis, no extra tissue required

icon-image-only4

Laboratory Developed Test, CLIA certified Lab

icon-accuracy-levels

NSCLC biomarker detection with high accuracy

vector-home-clinical

Scientific Advisory Board

Group 175

Dr. David Agus

Group 176

Dr. Tony Mok

Group 177

Dr. Ross Camidge

Group 178

Dr. Natasha Leighl

Group 179

Dr. Christian Rolfo

Group 180

Dr. Nir Peled

bg-home-numbers
img-technology

Our Technology

lmagene's state-of-the-art deep learning models have the capabilities of searching for all present phenotypic alterations and empowering the reporting of meaningful insights.

Book a Demo

Join our Partners

logo-partners-1 logo-partners-2 logo-partners-3
Learn More About Us
vector-jhome-partners-1
vector-jhome-partners-2